Home/Filings/4/0001062993-23-009245
4//SEC Filing

KIM DENNIS D 4

Accession 0001062993-23-009245

CIK 0001042074other

Filed

Apr 16, 8:00 PM ET

Accepted

Apr 17, 7:24 PM ET

Size

14.1 KB

Accession

0001062993-23-009245

Insider Transaction Report

Form 4
Period: 2023-04-13
KIM DENNIS D
Chief Medical Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2023-04-17$4.37/sh+112,219$490,397132,219 total
  • Exercise/Conversion

    Common Stock

    2023-04-13$4.37/sh+7,781$34,00327,781 total
  • Sale

    Common Stock

    2023-04-17$9.54/sh112,219$1,070,53620,000 total
  • Sale

    Common Stock

    2023-04-13$8.98/sh7,781$69,88020,000 total
  • Exercise/Conversion

    Employee Stock Option (right to buy)

    2023-04-137,781282,119 total
    Exercise: $4.37Exp: 2031-05-16Common Stock (7,781 underlying)
  • Exercise/Conversion

    Employee Stock Option (right to buy)

    2023-04-17112,219169,900 total
    Exercise: $4.37Exp: 2031-05-16Common Stock (112,219 underlying)
Footnotes (3)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.98 to $8.985, inclusive. The reporting person undertakes to provide to CymaBay Therapeutics, Inc., any security holder of CymaBay Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.30 to $9.80, inclusive. The reporting person undertakes to provide to CymaBay Therapeutics, Inc., any security holder of CymaBay Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • [F3]The original option grant vested as to 1/4 of the underlying shares on May 17, 2022 and vests as to 1/48 of the underlying shares monthly thereafter.

Issuer

CymaBay Therapeutics, Inc.

CIK 0001042074

Entity typeother

Related Parties

1
  • filerCIK 0001456750

Filing Metadata

Form type
4
Filed
Apr 16, 8:00 PM ET
Accepted
Apr 17, 7:24 PM ET
Size
14.1 KB